Phase 2
Completed N=20
Vitamin D to Prevent Autism in Newborn Siblings
Autistic Disorder
Source: ClinicalTrials.gov NCT01366885 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jun 2016
Primary outcomePrimary: Number of Children Who Developed Autism — 1 Children who developed autism
Summary
The purpose of this study is to determine whether by administering vitamin D to mothers who already have at least one child with autism and who are pregnant, that the vitamin D will prevent the recurrence of autism in the newborn sibling.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Children Who Developed Autism |
1 | — |
| SECONDARY Number of Mothers Who Developed Side Effects From Vitamin D |
— | — |
Eligibility Criteria
Inclusion Criteria
- Pregnant mothers who have had at least one child with autism spectrum disorder
Exclusion Criteria
- Child with autism must not be from a syndrome such as Fragile X syndrome, Retts Syndrome
- Mother must be before the third trimester
Data sourced from ClinicalTrials.gov (NCT01366885). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.